Case Report
Accepted on 04 Feb 2026
A rapid response to Obinutuzumab and Venetoclax in patients with nephrotic syndrome related to CLL: a report of two cases
in Blood Cancer
Frontiers in Hematology
- 103 views
- Frontiers in Hematology
- Blood Cancer
- Articles
Type at least 3 characters
84 articles
articles
Case Report
Published on 04 Feb 2026
Case Report: Chronic myelomonocytic leukemia initially diagnosed as immune thrombocytopenia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1748301
- 397 views
Original Research
Published on 30 Jan 2026
Long-term outcomes of hyperbaric oxygen pretreatment in autologous hematopoietic stem cell transplantation
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1733667
- 1,015 views
Case Report
Accepted on 26 Jan 2026
Two cases of Idiopathic Plasmacytic Lymphadenopathy subtype of Idiopathic Multicentric Castleman Disease with xanthelasma palpebrum from a Canadian center
in Blood Cancer
Frontiers in Hematology
- 325 views
Case Report
Published on 23 Jan 2026
Case Report: Durable response to PD-1 blockade after failure of ALK-targeted therapy and chemoimmunotherapy in ALK-positive large B-cell lymphoma
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1683981
- 943 views
Original Research
Accepted on 21 Jan 2026
Evaluating role of TNF-α in Tyrosine kinase Inhibitors-treated Chronic Myeloid Leukemia"
in Blood Cancer
Frontiers in Hematology
- 217 views
Original Research
Published on 21 Jan 2026
Too soon to switch? Early TKI switching vs. continuous monotherapy: long-term outcomes in chronic myeloid leukemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1730554
- 708 views
Original Research
Published on 12 Jan 2026
Myeloma patients’ attitudes and perceived burden of treatment administration routes and locations: insights from a pan-European survey
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1699930
- 1,572 views
Review
Published on 07 Jan 2026
To treat or not to treat: a state-of-the-art overview of smoldering multiple myeloma
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1706219
- 1,141 views
Case Report
Accepted on 28 Nov 2025
A Converging Pathology: Chediak-Higashi Syndrome and IEI-Associated Lymphoproliferative Disease. Case Report
in Blood Cancer
Frontiers in Hematology
- 661 views
Brief Research Report
Published on 13 Nov 2025
Portuguese real-world experience with ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1702446
- 1,632 views
Review
Published on 11 Nov 2025
A focus on LBCL patients in partial remission in the CAR-T era
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1675099
- 1,763 views
Case Report
Published on 10 Oct 2025
Case Report: Extramedullary plasmacytoma of the stomach: a rare manifestation of relapsed multiple myeloma
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1655966
- 1,483 views
Systematic Review
Published on 02 Oct 2025
The role of interventional radiology in pain management for multiple myeloma: a literature review
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1649720
- 2,126 views
Original Research
Published on 25 Sep 2025
H3K27me3 and HOXA9 expression predict prognosis in pediatric acute myeloid leukemia: an epigenetic-transcriptional correlation study
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1668408
- 1,984 views
- 1 citation
Brief Research Report
Published on 25 Sep 2025
Real-world data of azacitidine for relapsed/refractory nodal T-follicular helper cell lymphoma in 11 patients
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1638236
- 1,786 views
Brief Research Report
Published on 23 Sep 2025
Real-world experience of venetoclax target dosing with concomitant posaconazole in adult patients with acute myeloid leukemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1664425
- 2,287 views
Original Research
Published on 12 Sep 2025
Immune profile focusing on B-cell activating factor in B-cell malignancies
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1626886
- 1,739 views
Case Report
Published on 22 Aug 2025
Case report: A case of intravascular large B-cell lymphoma and related literature review
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1639726
- 1,737 views
Review
Published on 16 Jul 2025
The therapeutic perspective of relapsed/refractory Waldenström Macroglobulinemia: what comes next?
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1624046
- 2,773 views
Case Report
Published on 15 Jul 2025
Co-occurrence of AIDS and acute promyelocytic leukemia: a case report and review of the literature
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1527938
- 1,393 views
Brief Research Report
Published on 11 Jul 2025
The “added value” of enrolling hematological patients in clinical trials: a single-center experience
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1613099
- 1,445 views
Case Report
Published on 23 Jun 2025
Case Report: Contrasting outcomes and use of desmosine to monitor two patients treated with plasma cell-directed chemotherapy for gammopathy-driven pulmonary elastolysis in acquired cutis laxa
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1502322
- 970 views
Mini Review
Published on 19 Jun 2025
Understanding therapy-related AML: genetic insights and emerging strategies for high-risk patients
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1609642
- 4,569 views
- 2 citations